Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending May 09, 2016. The document serves as a notification of transactions involving directors, persons discharging managerial responsibilities, or connected persons, in accordance with DTR 3.1.4R (1) (a).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a disclosure of insider trading activity and does not contain financial performance data.
Material Changes
The filing discloses a specific transaction involving Mr. Nick Hirons, a Person Discharging Managerial Responsibilities. On May 05, 2016, Mr. Hirons sold 22,414.764 American Depositary Shares (ADS) at a price of $42.17 per ADS. The Company and Mr. Hirons were advised of this transaction on May 09, 2016.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the disclosed transaction.
Investor Verification Points
- Verify the total number of ADS sold by Mr. Nick Hirons (22,414.764).
- Confirm the execution date of the sale (May 05, 2016) and the notification date (May 09, 2016).
- Check the transaction price of $42.17 per ADS against market data for that date.
- Review the current holdings of Mr. Hirons post-transaction to assess remaining exposure.